Contract Pharma Q&A with Drew Bradley of Adare Pharma Solutions
More Content From Contract Pharma Q&A with Drew Bradley of Adare Pharma Solutions
-
Quickly Create Custom Oral Delivery Systems And Reduce Time To Market With Adaptdose™
Adare's Adaptdose™ technology can help streamline your project's development time and help get you to market faster.White Papers / Tech Papers Released on 03.24.2022
-
Formulation of Aqueous Core Poly(lactic acid) Microcapsules
This white paper demonstrates how single-step encapsulation of a water core can be achieved using Adare Pharma Solutions' Stratμm technology.White Papers / Tech Papers Released on 06.14.2021
-
How to Achieve Precise and Flexible Dosing with Multiparticulates
Multiparticulate systems have several advantages over conventional tablet or capsule formulations. Download this whitepaper to learn more.White Papers / Tech Papers Released on 04.30.2021
-
Formulation of Monodisperse Controlled-Release Quetiapine Microspheres
Adare’s Optimμm® technology offers a unique and efficient method of fabricating monodisperse microparticles at reduced development time.White Papers / Tech Papers Released on 12.03.2020
-
Expanding Solutions for Challenging APIs Through Coacervation
Download Adare Pharma Solutions' whitepaper to learn how the coacervation method can help solve your formulation challenges.White Papers / Tech Papers Released on 09.01.2020
